Leveraging 3Rs for Superior Cell Line Characterization

WEBINAR

In this webinar, you’ll learn:

• How the regulatory landscape is evolving to support sustainable approaches with respect to 3Rs in biosafety testing
• How a roadmap can be employed to drive replacement, reduction and refinement of the use of animals in quality control testing
• About recently published data supporting the use of Next Generation Sequencing for replacing in vivo testing for adventitious virus detection
• How the introduction of sustainable, alternative methods can help to drive reduced timelines for cell line characterization

With many technological advances in biologics safety testing, non-animal alternatives to classical animal tests have been developed, providing a foundation for a growing number of regulatory changes, which in turn provide a supportive framework for a 3Rs (replace, reduce, refine) approach in biologics safety testing.

In this webinar, we review the regulatory landscape and explore an approach to developing 3Rs roadmaps. We present recently published data demonstrating the value of next generation sequencing (NGS) as a replacement for in vivo testing for adventitious viruses, and discuss implementing the latest technologies, including NGS, in a faster cell line characterization package.